LUND, Sweden--(BUSINESS WIRE)--Regulatory News: NeuroVive Pharmaceutical AB (publ) (STO:NVP), the mitochondrial medicine company, announces the presentation of preclinical data from its Complex I deficiency discovery program at the 6th World Congress on Targeting Mitochondria in Berlin, Germany.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
